Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some
Patients with nasopharyngeal cancer who received the Chinese Sinovac COVID-19 vaccine did better on immune checkpoint inhibitor therapy compared with unvaccinated patients, early data suggest.
United States Nordrhein Westfalen Jian Li Alexandre Malek Louisiana State University Health Shreveport Medscape Coronavirus Resource Center
Source: medscape.com